Tech transfer in oral solid dose (OSD) manufacturing is one of the most critical, and often underestimated, phases in the drug development lifecycle.
Ahmedabad: Intas Pharma has announced the appointment of Mithrasekhar Reddy Gundre as Deputy General Manager - Downstream ...
KELOWNA, BC / ACCESS Newswire / November 12, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides this ...
Quality, stability, sustainability, and the increased and thoughtful integration of artificial intelligence are foremost in the minds of those on the leading edge of testing trends.
Operating globally across multiple jurisdictions, pharmaceutical companies must protect sensitive patient data, clinical ...
Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers. The president signed an executive order to promote domestic pharma production Monday, and said that news on drug ...
5 天on MSN
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI ...
Recursion Pharmaceuticals (NASDAQ: RXRX) has been a pioneer in using artificial intelligence (AI) to improve the drug ...
KELOWNA, BC / ACCESS Newswire / November 12, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides this upda ...
Celebrate 100 years of VA medical breakthroughs and discover how to partner in driving the future of healthcare innovation.
Company reports $14.3 million in revenue in Q3’25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license ...
UBS Global Healthcare Conference 2025 November 11, 2025 9:30 AM ESTCompany ParticipantsRobert McMahon - Senior ...
Company reports $14.3 million in revenue in Q3'25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license and collaboration revenue - - Reports positive feedback from the FDA ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果